-
Takeda's Speculative Interest In Synergy Soothes Stomach Pains; Canaccord Says Buy
Wednesday, January 25, 2017 - 3:55pm | 366Canaccord Genuity said it views Takeda Pharmaceutical Co Ltd (ADR) (OTC: TKPYY)’s speculated interest in buying Synergy Pharmaceuticals Inc (NASDAQ: SGYP) as a positive step. The potential deal could boost its GI (gastrointestine) portfolio. Speculative Interest Commenting on the indication...